Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
Reduce the Risk of Future CV Events | PRALUENT® (alirocumab) Injection
Learn about PRALUENT, which can help adults with cardiovascular disease reduce their risk of heart attack, stroke, and certain chest pain conditions that may require hospitalization. Find helpful documents such as doctor talking points and other PRALUENT downloadable resources. Read Important Safety Information on website.
This website is hosted with Intouch Group, LLC, which reserves the following IP addresses for praluent.com: 192.103.124.92. Moreover, DNS used with this website include ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com, ns7.markmonitor.com. Subnet identifier ranges from 192.103.124.0 to 192.103.125.255. Classless Inter-Domain Routing (CIDR) is 192.103.124.0/23. ARIN net type is Direct Allocation.
Daily Visitors
Last scanned
Domain Age
Global Rank
ns1.markmonitor.com
ns2.markmonitor.com
ns3.markmonitor.com
ns4.markmonitor.com
ns5.markmonitor.com
ns6.markmonitor.com
ns7.markmonitor.com
{{value}}
2014-04-25
2024-04-25
MarkMonitor Inc.
{{value}}
The registrar of praluent.com is MarkMonitor Inc. and the name expires on 2024-04-25. According to open source data, you can reach the owner at domains@regeneron.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
89
N/A
N/A
N/A
N/A
N/A
N/A
N/A
534
N/A
N/A